Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
Top Cited Papers
Open Access
- 6 June 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (23), 4778-4781
- https://doi.org/10.1182/blood-2013-01-478891
Abstract
Key Points: Evidence exists that ELN criteria for response in ET and PV issued in 2009 do not provide relevant measures of benefit for patients. Revised recommendations for assessing response are provided.Keywords
This publication has 16 references indexed in Scilit:
- Genetic predisposition to molecular response in patients with myeloproliferative neoplasms treated with hydroxycarbamideLeukemia Research, 2013
- Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia veraBlood, 2012
- Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients?Leukemia, 2011
- The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patientsBlood, 2011
- Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteriaBlood, 2010
- A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasmsBritish Journal of Haematology, 2010
- Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2V617F clones without affecting TET2 mutant cellsLeukemia, 2010
- Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceBlood, 2009
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraPublished by American Society of Hematology ,2008
- Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatmentLeukemia, 2007